Literature DB >> 11036846

Pool exercise combined with an education program for patients with fibromyalgia syndrome. A prospective, randomized study.

K Mannerkorpi1, B Nyberg, M Ahlmén, C Ekdahl.   

Abstract

OBJECTIVE: To evaluate the effects of 6 months of pool exercise combined with a 6 session education program for patients with fibromyalgia syndrome (FM).
METHODS: The study population comprised 58 patients, randomized to a treatment or a control group. Patients were instructed to match the pool exercises to their threshold of pain and fatigue. The education focused on strategies for coping with symptoms and encouragement of physical activity. The primary outcome measurements were the total score of the Fibromyalgia Impact Questionnaire (FIQ) and the 6 min walk test, recorded at study start and after 6 mo. Several other tests and instruments assessing functional limitations, severity of symptoms, disabilities, and quality of life were also applied.
RESULTS: Significant differences between the treatment group and the control group were found for the FIQ total score (p = 0.017) and the 6 min walk test (p < 0.0001). Significant differences were also found for physical function, grip strength, pain severity, social functioning, psychological distress, and quality of life.
CONCLUSION: The results suggest that a 6 month program of exercises in a temperate pool combined with education will improve the consequences of FM.

Entities:  

Mesh:

Year:  2000        PMID: 11036846

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  61 in total

1.  [Fibromyalgia].

Authors:  M Romera Baurés
Journal:  Aten Primaria       Date:  2001-05-15       Impact factor: 1.137

2.  Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial.

Authors:  Michael C Hsu; Howard Schubiner; Mark A Lumley; John S Stracks; Daniel J Clauw; David A Williams
Journal:  J Gen Intern Med       Date:  2010-06-08       Impact factor: 5.128

3.  Clinical utility of the Hospital Anxiety and Depression Scale (HADS) for an outpatient fibromyalgia education program.

Authors:  Seungree Nam; Diane Tin; Lorna Bain; J Carter Thorne; Liane Ginsburg
Journal:  Clin Rheumatol       Date:  2013-09-01       Impact factor: 2.980

Review 4.  Interventions for the prevention and management of neck/upper extremity musculoskeletal conditions: a systematic review.

Authors:  M G Boocock; P J McNair; P J Larmer; B Armstrong; J Collier; M Simmonds; N Garrett
Journal:  Occup Environ Med       Date:  2006-09-14       Impact factor: 4.402

5.  Effects of Aquatic Therapy and Land-Based Therapy versus Land-Based Therapy Alone on Range of Motion, Edema, and Function after Hip or Knee Replacement: A Systematic Review and Meta-analysis.

Authors:  Alison J Gibson; Nora Shields
Journal:  Physiother Can       Date:  2015       Impact factor: 1.037

6.  [Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome].

Authors:  M Schiltenwolf; W Häuser; E Felde; C Flügge; R Häfner; M Settan; M Offenbächer
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 7.  A realistic approach to managing patients with fibromyalgia.

Authors:  Geoffrey O Littlejohn; Janine Walker
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

8.  Effects of muscle strengthening versus aerobic exercise program in fibromyalgia.

Authors:  Ciğdem Bircan; Seide Alev Karasel; Berrin Akgün; Ozlem El; Serap Alper
Journal:  Rheumatol Int       Date:  2007-11-03       Impact factor: 2.631

Review 9.  Pharmaceutical treatment options for fibromyalgia.

Authors:  Leslie J Crofford
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

Review 10.  Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Winfried Häuser; Petra Klose; Jost Langhorst; Babak Moradi; Mario Steinbach; Marcus Schiltenwolf; Angela Busch
Journal:  Arthritis Res Ther       Date:  2010-05-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.